Reishi Mushroom 600 mg by Swanson — Ingredients, Evidence & Safety

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Capsule(s) Serving Size

30 Servings

Non-Nutrient/Non-Botanical Product Type

0% Evidence Coverage

Supplement Facts — Evidence Check

Total Carbohydrate

1 Gram(s) (1% DV)

Reishi Mushroom

1.2 Gram(s)

📊 Market median: 340.0mg (243 products) 📚 3 studies — no high-quality reviews

This product: 1.2mg

Other Ingredients

Gelatin Magnesium Stearate Silica Microcrystalline Cellulose

Label Claims — Verification

❓ All Other

❓ Structure/Function

All Other (98% of products) Structure/Function (86% of products) Nutrient (9% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating)

Product Information

📋 Directions for Use

Suggested use: As a dietary supplement, take two capsules per day with water.

⚠️ Warnings & Precautions

Warning: For adults only. Keep out of reach of children.

Do not use if you are pregnant or nursing. Consult your physician before using this or any product if you are taking medication or have medical condition.

Discontinue use if unusual symptoms occur. Do not use if seal is broken.

🧪 Formulation Notes

Maintains immune health Supports liver health and detoxification Supports a normal response to daily stress

Immune health

Reishi Mushroom 600 mg per capsule

Additional Information

Science-backed quality since 1969

Store in a cool, dry place.

Product Details

UPC / SKU 0 87614 11444 6

DSLD Entry Date 2024-05-23

Product Type Non-Nutrient/Non-Botanical

Form Capsule

Brand Swanson

DSLD ID 308732

Data Updated 2026-04-11

Research Evidence

6 Research Sources

60 Avg Quality Score

3 Meta Analysis

3 Rct

B Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors

Meta Analysis The Cochrane database of systematic reviews 2015

PubMed DOI Cochrane

B Ganoderma lucidum (Reishi mushroom) for cancer treatment

Meta Analysis The Cochrane database of systematic reviews 2016

PubMed DOI Cochrane

B Ganoderma lucidum (Reishi mushroom) for cancer treatment

Meta Analysis The Cochrane database of systematic reviews 2012

PubMed DOI Cochrane

C Dynamic biomarkers indicate the immunological benefits provided by Ganoderma spore powder in post-operative breast and lung cancer patients

Rct Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2021

PubMed DOI

C Efficacy of Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes) Supplementation on Psychological Stress and Selective Fitness Profile Parameters in Female College Students in West Bengal, India

Rct International journal of medicinal mushrooms 2024

PubMed DOI

C Preliminary Efficacy and Safety of Reishi & Privet Formula on Quality of Life Among Non-Small Cell Lung Cancer Patients Undergoing Chemotherapy: A Randomized Placebo-Controlled Trial

Rct Integrative cancer therapies 2020

PubMed DOI

View all evidence for Reishi →